These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12659424)

  • 1. Lymphokine-activated killer cells can kill target cells not only by early killing but also by late killing, and the late killing level against autotumor cell line.
    Komatsu F; Ishiguro K
    Oncol Res; 2003; 13(4):235-41. PubMed ID: 12659424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
    Hong WS; Kim CM; Lee JO; Kang TW; Yun TK; Kim CY
    Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-cell adhesion-independent killing due to lymphokine-activated killer cells against glioblastoma cell lines.
    Komatsu F; Masuda T
    Oncol Res; 2000; 12(9-10):371-81. PubMed ID: 11697816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphokine-activated killer cell induced from cord blood].
    Wang YF; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):78-81, 122-3. PubMed ID: 8033630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lymphokine-activated killer cells generation in vitro by soluble factors released from mixed human tumor and peripheral blood mononuclear adherent cells culture.
    Eisenthal A; Barbarsteyn E; Gitstein G; Lifschitz-Mercer B
    Cancer Invest; 2006 Feb; 24(1):28-34. PubMed ID: 16466989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokine-activated killing by human intestinal lymphocytes.
    Ebert EC; Roberts AI
    Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infiltrative and cytolytic activities of lymphokine-activated killer (LAK) cells against a human glioma mass: ultrastructural analysis using a three-dimensional multicellular spheroid model].
    Iwasaki K
    Nihon Geka Hokan; 1990 Jan; 59(1):39-54. PubMed ID: 2130768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer.
    Wang ZP; Chen YR; Zheng RL; Lu JZ; Wang JJ
    Acta Pharmacol Sin; 2002 Mar; 23(3):257-62. PubMed ID: 11918852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer (NK) and lymphokine-activated killer (LAK) activities in a patient who recovered from cancer, and the characteristics of LAK cells generated from CD4-CD8- and CD8+ peripheral blood lymphocytes.
    Komatsu F; Kihara K
    Clin Immunol Immunopathol; 1995 Oct; 77(1):75-81. PubMed ID: 7554487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model.
    Iwasaki K; Kikuchi H; Miyatake S; Aoki T; Yamasaki T; Oda Y
    Cancer Res; 1990 Apr; 50(8):2429-36. PubMed ID: 2317827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of cell surface structures involved in cytotoxicity mediated by lymphokine activated killer cells.
    Bean P; Agah R; Mazumder A
    J Biol Response Mod; 1990 Feb; 9(1):92-7. PubMed ID: 2181073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of lymphokine-activated killer cell activity by lentinan.
    Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
    Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of cloned human lymphokine-activated killer (LAK) cells killing human leukemia cells in vitro].
    Jiang CY
    Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):163-6. PubMed ID: 1396052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lymphokine-activated killer cells develop syngeneic killing ability.
    Gallagher G; Findlay J; al-Azzawi FA
    Immunology; 1989 Mar; 66(3):471-4. PubMed ID: 2784783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of chromosome 6-associated target structures by human lymphokine-activated killer cells.
    Helander T; Timonen T; Kalliomäki P; Schröder J
    J Immunol; 1991 Sep; 147(6):2063-7. PubMed ID: 1890312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electron microscopic observation on the killing of human lung carcinoma cells by lymphokine-activated killer cells (LAK cells) in vitro].
    Shi J
    Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):319-21, 22. PubMed ID: 2169980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface recognition determinants involved in triggering the lymphokine activated killer cell phenomenon: enhanced killing of modified "anti-self" targets by varying LAK culture conditions.
    Finkelstein DM; Miller RG
    J Otolaryngol; 1990 Oct; 19(5):294-8. PubMed ID: 2262945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between killing activity towards the murine L929 cell line and expression of membrane-associated lymphotoxin-related molecule of human lymphokine-activated killer cells.
    Miyake M; Horiuchi A; Kimura K; Abe Y; Kimura S; Hitsumoto Y
    Eur J Immunol; 1992 Aug; 22(8):2147-52. PubMed ID: 1639109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
    Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.